title: [Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].
authors.affiliation: Klinik für Infektionskrankheiten und Spitalhygiene, Universitätsspital Zürich.
authors.forename: Peter
authors.initials: P
authors.lastname: Schreiber
authors.affiliation: Klinik für Kardiologie, Universitätsspital Zürich.
authors.forename: Ivan
authors.initials: I
authors.lastname: Fauchère
authors.affiliation: Herzklinik Hirslanden, Zürich.
authors.forename: Christophe
authors.initials: C
authors.lastname: Wyss
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D000241:Adenosine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D000077144:Clopidogrel; D003327:Coronary Disease / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D061345:Early Medical Intervention; D058006:General Practice; D019983:Guideline Adherence; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D000068799:Prasugrel Hydrochloride; D058921:Purinergic P2Y Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D055502:Secondary Prevention; D015607:Stents; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use; D000077486:Ticagrelor; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D000077486:Ticagrelor; D000241:Adenosine; D013988:Ticlopidine; D001241:Aspirin